Objective: Chile is one of the few high-income countries in Latin America, being a pioneer in implementing a national newborn screening (NBS) program in 1992. Currently, it covers 98% of the population, but no long-term outcomes have been described so far. The aim of this study was to report the neurocognitive outcomes of children with congenital hypothyroidism (CH) diagnosed by the NBS program in Chile between 2005 and 2012 and to identify variables associated with the outcomes. Methods: We performed a case-control study in children with CH born in the two largest regions of the country. The Leiter-R and TEVI-R tests were administered at home to 69 children with CH and 68 matched control subjects. Other variables affecting cognition were obtained. Multivariate logistic regression analyses were performed for Leiter-R and TEVI-R tests, using a model for cases alone and another model for cases and controls. Results: No differences in Leiter-R and TEVI-R results were observed between children with CH and the control group. Children who performed better, regardless of whether they had CH, had a higher family income and more assets. Conclusions: These results suggest that the Chilean NBS program strategy results in children with normal language, attention, and memory development. Socioeconomic disadvantage represents a significant detriment in cognitive function.

1.
Grosse
SD
,
Van Vliet
G
.
Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level?
Arch Dis Child
.
2011
;
96
(
4
):
374
9
. .
2.
Nam
JY
,
Choi
Y
,
Jung
MK
,
Shin
J
,
Cho
KH
,
Kim
W
,
The effect of neonatal hypothyroidism and low family income on intellectual disability: a population-based cohort study
.
PLoS One
.
2018
;
13
(
11
):
e0205955
.
3.
Emerson
E
.
Mothers of children and adolescents with intellectual disability: social and economic situation, mental health status, and the self-assessed social and psychological impact of the child’s difficulties
.
J Intellect Disabil Res
.
2003
;
47
(
4–5
):
385
99
.
4.
Maulik
PK
,
Mascarenhas
MN
,
Mathers
CD
,
Dua
T
,
Saxena
S
.
Prevalence of intellectual disability: a meta-analysis of population-based studies
.
Res Dev Disabil
.
2011
;
32
(
2
):
419
36
. .
5.
Leonard
H
,
de Klerk
N
,
Bourke
J
,
Bower
C
.
Maternal health in pregnancy and intellectual disability in the offspring: a Population-Based Study
.
Ann Epidemiol
.
2006
;
16
(
6
):
448
54
. .
6.
Huang
J
,
Zhu
T
,
Qu
Y
,
Mu
D
.
Prenatal, perinatal and neonatal risk factors for intellectual disability: a systemic review and meta- analysis
.
PLoS One
.
2016
;
11
(
4
):
e0153655
.
7.
Rovet
JF
.
Children with congenital hypothyroidism and their siblings: do they really differ?
Pediatrics
.
2005
;
115
(
1
):
e52
7
. .
8.
Oerbeck
B
,
Sundet
K
,
Kase
BF
,
Heyerdahl
S
.
Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults
.
Pediatrics
.
2003
;
112
(
4
):
923
30
. .
9.
Albert
BB
,
Heather
N
,
Derraik
JGB
,
Cutfield
WS
,
Wouldes
T
,
Tregurtha
S
,
Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring
.
J Clin Endocrinol Metab
.
2013
;
98
(
9
):
3663
70
.
10.
Aleksander
P
,
Brückner-Spieler
M
,
Stöhr
AM
,
Lankes
E
,
Kühnen
P
,
Schnabel
D
,
Mean high dose L-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism
.
J Clin Endocrinol Metab
.
2018
;
103
(
4
):
1459
69
.
11.
Jones
PW
,
Coleman
D
.
World bank [Internet]
.
United Nations Educ
;
2010
. p.
94
136
.
12.
Borrajo
GJC
.
Newborn screening in latin america: a brief overview of the state of the art
.
Am J Med Genet C Semin Med Genet
.
2021
;
187
(
3
):
322
28
.
13.
Van Der Sluijs Veer
L
,
Kempers
MJ
,
Wiedijk
BM
,
Last
BF
,
Grootenhuis
MA
,
Vulsma
T
.
Evaluation of cognitive and motor development in toddlers with congenital hypothyroidism diagnosed by neonatal screening
.
J Dev Behav Pediatr
.
2012
;
33
(
8
):
633
40
. .
14.
Heyerdahl
S
,
Oerbeck
B
.
Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables
.
Thyroid
.
2003
;
13
(
11
):
1029
38
. .
15.
Echeverría
M
,
Herrera
M
,
Herrera
J
.
Test de vocabulario en imágenes revisado (TEVI-R)
. 3rd ed.
Univ Concepción
;
2002
.
16.
Roid
GH
,
Pomplun
M
,
Martin
JJ
.
Nonverbal intellectual and cognitive assessment with the leiter international performance scale: revised (Leiter-R). Practitioner’s guide to assessing intelligence and achievement
.
Hoboken, NJ, USA
:
John Wiley & Sons Inc
;
2009
. p.
265
90
.
17.
Dimitropoulos
A
,
Molinari
L
,
Etter
K
,
Torresani
T
,
Lang-Muritano
M
,
Jenni
OG
,
Children with congenital hypothyroidism: long-term intellectual outcome after early high-dose treatment
.
Pediatr Res
.
2009
;
65
(
2
):
242
8
.
18.
Cornejo
V
,
Raimann
E
,
Cabello
JF
,
Valiente
A
,
Becerra
C
,
Opazo
M
,
Past, present and future of newborn screening in Chile
.
J Inherit Metab Dis
.
2010
;
33
(
Suppl 3
):
S301
6
.
19.
Chiesa
A
,
Prieto
L
,
Mendez
V
,
Papendieck
P
,
Calcagno
ML
,
Gruñeiro-Papendieck
L
.
Prevalence and etiology of congenital hypothyroidism detected through an argentine neonatal screening program (1997–2010)
.
Horm Res Paediatr
.
2013
;
80
(
3
):
185
92
. .
20.
Campos
MLP
,
Musso
M
,
Keselman
A
,
Gruñeiro
L
,
Bergadá
I
,
Chiesa
A
.
Cognitive profiles of patients with early detected and treated congenital hypothyroidism
.
Arch Argent Pediatr
.
2017
;
115
(
1
):
12
7
.
21.
Grüters
A
,
Liesenkötter
KP
,
Zapico
M
,
Jenner
A
,
Dütting
C
,
Pfeiffer
E
,
Results of the screening program for congenital hypothyroidism in Berlin (1978–1995)
.
Exp Clin Endocrinol Diabetes
.
1997
;
105 Suppl 4
:
28
31
.
22.
Huo
K
,
Zhang
Z
,
Zhao
D
,
Li
H
,
Wang
J
,
Wang
X
,
Risk factors for neurodevelopmental deficits in congenital hypothyroidism after early substitution treatment
.
Endocr J
.
2011
;
58
(
5
):
355
61
.
23.
Kreisner
E
,
Schermann
L
,
Camargo-Neto
E
,
Gross
JL
.
Predictors of intellectual outcome in a cohort of brazilian children with congenital hypothyroidism
.
Clin Endocrinol
.
2004
;
60
(
2
):
250
5
. .
24.
Schwab
JF
,
Lew-Williams
C
.
Language learning, socioeconomic status, and child-directed speech
.
Wiley Interdiscip Rev Cogn Sci
.
2016
;
7
(
4
):
264
75
. .
25.
Hair
NL
,
Hanson
JL
,
Wolfe
BL
,
Pollak
SD
.
Association of child poverty, brain development, and academic achievement
.
JAMA Pediatr
.
2015
;
169
(
9
):
822
9
. .
26.
Ministerio de Desarrollo Social. Gobierno de Chile
.
Encuesta casen [Internet]
.
2017
:
4
80
.
27.
Milman
HM
,
Castillo
CA
,
Sansotta
AT
,
Delpiano
PV
,
Murray
J
.
Scaling up an early childhood development programme through a national multisectoral approach to social protection: lessons from Chile Crece Contigo
.
BMJ
.
2018
;
363
:
k4513
. .
28.
Robinette
JW
,
Charles
ST
,
Gruenewald
TL
.
Neighborhood socioeconomic status and health: a longitudinal analysis
.
J Community Health
.
2017
;
42
(
5
):
865
71
. .
29.
Pearce
N
.
Analysis of matched case-control studies
.
BMJ
.
2016
;
352
:
i969
. .
30.
Grob
F
,
Torres
C
.
Newborn screening for congenital hypothyroidism in Chile workshop SLEP
;
2021
. Available from: https://slep-endocrino.com/workshop/.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.